Health Condition 1: K117- Disturbances of salivary secretion
Conditions
Interventions
Intervention1: Atropine Sulphate drops (1% w/v): atropine sulphate drops administered orally as per dosage guidelines 0.01-0.02 mg/kg of body weight
Control Intervention1: Placebo: Distilled water dro
Sponsors
Department of Pedodontics and Preventive Dentistry
Eligibility
Inclusion criteria
Inclusion criteria: Children reporting to OPD for elective dental procedures. Children belonging to group 1â??2 (healthy or minor disease) according to the ASA (American Society of Anesthesiologists) Physical Status Classification System. Children with salivary flow above baseline.
Exclusion criteria
Exclusion criteria: 1. Children with oral mucosal lesions. 2. Children undergoing radiotherapy or chemotherapy. 3. Children on medications for underlying systemic conditions. 4. Known cases of cardiac conditions 5. Children with known allergy to atropine.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To quantitatively assess decrease in salivary secretion post administration of atropine sulphate drops during routine dental procedures.Timepoint: the salivary flow (stimulated and unstimulated) assessed over 3 time intervals 0 mins, 60 mins and 90 mins | — |
Secondary
| Measure | Time frame |
|---|---|
| To assess the duration of regression to baseline salivary index post administration of drops.Timepoint: the decrease in baseline salivary index compared from 0 min, 60 mins and 90 mins. | — |
Countries
India
Contacts
Public ContactSHANNON SAMUEL
CHRISTIAN DENTAL COLLEGE, Ludhiana
Outcome results
None listed